FDA clears prescription nasal flu vaccine for home delivery
In a significant development, the U.S. Food and Drug Administration (FDA) has approved AstraZeneca’s FluMist nasal flu vaccine for use at home. This groundbreaking approval allows people, especially those who prefer non-injectable options, to administer the flu vaccine themselves or through a caregiver in the comfort of their own home, although a doctor’s prescription is still required. The initiative, which is expected to be available through online pharmacies this fall, aims to make flu prevention more accessible and convenient. AstraZeneca plans to launch a dedicated service on the FluMist Home website, where users can complete a pharmacist-supervised health questionnaire before…
